Characteristics and hematological indicators predictors of immunotherapy response in advanced non-small cell lung cancer.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42277693

Dedong Cao; Hua He; Nan Zhao; Wensi Zhao; Xiang Cheng; Xinyu Wu

Jun 13, 2026